You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 161 No. 2, January 22, 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (13)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Routine Measurement of Pleural Fluid Amylase Is Not Indicated

Paul Branca, MD; R. Michael Rodriguez, MD; Jeffrey T. Rogers, RRT; Dereje S. Ayo, MD; J. Phillip Moyers, MD; Richard W. Light, MD

Arch Intern Med. 2001;161:228-232.

Background  The routine measurement of pleural fluid amylase is frequently recommended, but the cost-effectiveness of this procedure is unknown.

Methods  To assess the utility of routine measurement of pleural fluid amylase in evaluating pleural effusions, we measured amylase, glucose, lactate dehydrogenase, and protein levels and blood cell counts in 379 patients undergoing thoracentesis during a 22-month period from 1997 to 1999. Of these, 199 had effusions after cardiac surgery; 61, malignant; 48, transudative; 28, parapneumonic; 2, chylous; 2, rheumatoid; 1, tuberculous; and 1, from chronic pleuritis. There were 37 exudates of unknown origin.

Results  Measurement of pleural fluid amylase levels did not assist in determining the origin of the effusion in any of the patients. Amylase levels greater than 100 U/L (normal serum level in our laboratory is 30-110 U/L) were found in 5 (1.3%) of 379 patients: 1 patient with congestive heart failure (amylase, 173 U/L), 2 with post–cardiac surgery effusions (144 U/L and 130 U/L), 1 with pneumonia (109 U/L), and 1 with lung cancer (105 U/L).

Conclusions  The routine measurement of pleural fluid amylase levels is neither clinically indicated nor cost-effective. We suggest that pleural fluid serum amylase levels be measured only if there is a pretest suspicion of acute pancreatitis, chronic pancreatic disease, or esophageal rupture.


From the Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University (Drs Branca and Light), and Pulmonary Disease Program, Department of Medicine (Drs Rodriguez, Ayo, and Light and Mr Rogers), and Department of Radiology (Dr Moyers), St Thomas Hospital, Nashville, Tenn.

Corresponding author: Richard W. Light, MD, Director of Pulmonary Disease Program, St Thomas Hospital, PO Box 380, 4220 Harding Rd, Nashville, TN 37202 (e-mail: rlight98{at}yahoo.com).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pleural Effusion
Light
NEJM 2002;346:1971-1977.
FULL TEXT  

Amylase Levels in Pleural Effusions : A Consecutive Unselected Series of 841 Patients
Villena et al.
Chest 2002;121:470-474.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.